Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
42
pubmed:dateCreated
2005-10-17
pubmed:abstractText
The rhodopsin/transducin-coupled vertebrate vision system has served as a paradigm for G protein-coupled signaling. We have taken advantage of this system to identify new types of constitutively active, transducin-alpha (alphaT) subunits. Here we have described a novel dominant-negative mutation, made in the background of a chimera consisting of alphaT and the alpha subunit of G(i1) (designated alphaT*), which involves the substitution of a conserved arginine residue in the conformationally sensitive Switch 3 region. Changing Arg-238 to either lysine or alanine had little or no effect on the ability of alphaT* to undergo rhodopsin-stimulated GDP-GTP exchange, whereas substituting glutamic acid for arginine at this position yielded an alphaT* subunit (alphaT*(R238E)) that was incapable of undergoing rhodopsin-dependent nucleotide exchange and was unable to bind or stimulate the target/effector enzyme (cyclic GMP phosphodiesterase). Moreover, unlike the GDP-bound forms of alphaT*, alphaT*(R238A) and alphaT*(R238K), the alphaT*(R238E) mutant did not respond to aluminum fluoride (AlF4(-)), as read out by changes in Trp-207 fluorescence. However, surprisingly, we found that alphaT*(R238E) effectively blocked rhodopsin-catalyzed GDP-GTP exchange on alphaT*, as well as rhodopsin-stimulated phosphodiesterase activity. Analysis by high pressure liquid chromatography indicated that the alphaT*(R238E) mutant exists in a nucleotide-free state. Nucleotide-free forms of G alpha subunits were typically very sensitive to proteolytic degradation, but alphaT*(R238E) exhibited a resistance to trypsin-proteolysis similar to that observed with activated forms of alphaT*. Overall, these findings indicated that by mutating a single residue in Switch 3, it is possible to generate a unique type of dominant-negative G alpha subunit that can effectively block signaling by G protein-coupled receptors.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Aluminum Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Arginine, http://linkedlifedata.com/resource/pubmed/chemical/Cyclic GMP, http://linkedlifedata.com/resource/pubmed/chemical/Fluorides, http://linkedlifedata.com/resource/pubmed/chemical/Guanosine 5'-O-(3-Thiotriphosphate), http://linkedlifedata.com/resource/pubmed/chemical/Guanosine Diphosphate, http://linkedlifedata.com/resource/pubmed/chemical/Guanosine Triphosphate, http://linkedlifedata.com/resource/pubmed/chemical/Nucleotides, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Rhodopsin, http://linkedlifedata.com/resource/pubmed/chemical/Transducin, http://linkedlifedata.com/resource/pubmed/chemical/Trypsin, http://linkedlifedata.com/resource/pubmed/chemical/aluminum fluoride
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
21
pubmed:volume
280
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
35696-703
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:16103122-Aluminum Compounds, pubmed-meshheading:16103122-Animals, pubmed-meshheading:16103122-Arginine, pubmed-meshheading:16103122-Catalysis, pubmed-meshheading:16103122-Cattle, pubmed-meshheading:16103122-Chromatography, High Pressure Liquid, pubmed-meshheading:16103122-Cyclic GMP, pubmed-meshheading:16103122-Dose-Response Relationship, Drug, pubmed-meshheading:16103122-Fluorides, pubmed-meshheading:16103122-Genes, Dominant, pubmed-meshheading:16103122-Guanosine 5'-O-(3-Thiotriphosphate), pubmed-meshheading:16103122-Guanosine Diphosphate, pubmed-meshheading:16103122-Guanosine Triphosphate, pubmed-meshheading:16103122-Models, Biological, pubmed-meshheading:16103122-Models, Molecular, pubmed-meshheading:16103122-Mutation, pubmed-meshheading:16103122-Nucleotides, pubmed-meshheading:16103122-Point Mutation, pubmed-meshheading:16103122-Protein Conformation, pubmed-meshheading:16103122-Recombinant Fusion Proteins, pubmed-meshheading:16103122-Recombinant Proteins, pubmed-meshheading:16103122-Retina, pubmed-meshheading:16103122-Rhodopsin, pubmed-meshheading:16103122-Signal Transduction, pubmed-meshheading:16103122-Spectrometry, Fluorescence, pubmed-meshheading:16103122-Time Factors, pubmed-meshheading:16103122-Transducin, pubmed-meshheading:16103122-Trypsin
pubmed:year
2005
pubmed:articleTitle
A switch 3 point mutation in the alpha subunit of transducin yields a unique dominant-negative inhibitor.
pubmed:affiliation
Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, N.I.H., Extramural